European Commission logo
English English
CORDIS - EU research results
CORDIS

EU Training Network in understanding the molecular regulation and the role of endo-lysosomal processes in cardio-metabolic diseases

Project description

The role of the endo-lysosomal system in cardio-metabolic diseases

Metabolic homeostasis depends on the endo-lysosomal system, which acquires the essential lipids and nutrients to meet the cells' needs. Defects in this system are associated with cardiovascular disease, diabetes and other metabolic disorders. The scope of the EU-funded EndoConnect project is to understand the interconnection between the endo-lysosomal system and metabolism. Scientists will focus on the regulation of endo-lysosomal processes, its role in therapeutics efficiency and the mechanisms that contribute to disease. Moreover, through an interdisciplinary training programme, the project will provide early-stage researchers with state-of-the-art scientific, technical and transferable skills for a career in the field.

Objective

The endo-lysosomal system is essential to acquire lipids and nutrients according to the need of the cell and, subsequently, to maintain metabolic homeostasis. The strong connection between the endo-lysosomal system and metabolism is reflected in the observations that defects in this system are correlated with cardio-metabolic disorders, such as cardiovascular disease, type 2 diabetes and non-alcoholic fatty liver disease. The molecular mechanisms that interconnect the endo-lysosomal system with metabolism are, however, poorly understood. This can be largely explained by the fact that (1) endo-lysosomal and metabolic research are carried out independent of each other and (2) the number of model systems to study endo-lysosomal processes at an organismal and clinical level are limited. It is the ambition of EndoConnect to change this by bringing top scientists and industrial partners together to train early stage researchers in interdisciplinary research, with the focus on translating key findings from cellular and animal models to patients with cardio-metabolic diseases. It is our mission to: (1) understand the molecular organization and regulation of endo-lysosomal processes, (2) elucidate how metabolism and endo-lysosomal processes are intertwined, (3) understand how defects in the endo-lysosomal system contribute to the development of cardio-metabolic diseases and, finally, (4) how the endo-lysosomal system contributes to the efficiency of therapeutics. EndoConnect will provide an international training program for early stage researchers to acquire knowledge and state-of-the-art scientific, technical, and transferable skills to connect molecular and cell biology research with physiology and biomedical research towards translation. We expect that EndoConnect will increase our understanding of the molecular interrelation of the endo-lysosomal system with cardio-metabolic diseases, which will pave the road for novel diagnostics and therapeutics.

Coordinator

ACADEMISCH ZIEKENHUIS GRONINGEN
Net EU contribution
€ 531 239,76
Address
HANZEPLEIN 1
9713 GZ Groningen
Netherlands

See on map

Region
Noord-Nederland Groningen Overig Groningen
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 531 239,76

Participants (11)